logo
logo

Eyenovia Inc. raised $50 million in a PIPE financing, with Chardan as the sole placement agent. The funds will be used to acquire over 1 million HYPE tokens, positioning Eyenovia as a top validator on Hyperliquid.

Jun 18, 2025•28 days ago

Amount Raised

$50 Million

New YorkManufacturingHealth Care

Description

Chardan acted as sole placement agent in Eyenovia Inc.'s $50 million PIPE financing. The proceeds are being used to acquire over 1 million HYPE tokens, making Eyenovia the first U.S.-listed company to hold HYPE in its treasury. This transaction will position Eyenovia as a top validator on the Hyperliquid network. The financing involves non-voting convertible preferred stock and warrants, potentially raising up to $150 million total.

Company Information

Company

Eyenovia

Location

295 MADISON AVENUE,

New York, New York, United States

About

Eyenovia, Inc. is a pioneering digital ophthalmic technology company and the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE. With this dual focus, Eyenovia continues to revolutionize topical eye treatment while providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-generating blockchains in the world. Shareholders are expected to benefit from a gradually compounding exposure to HYPE, both from its native staking yield and additional revenues generated from opportunities uniquely available onchain.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People